9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Fluidx Medical Technology, Inc.
Tempus AI
Taproot Health
Bayer
Celgene
InSightec
InSightec
OPKO Health, Inc.
InSightec
Merck Sharp & Dohme LLC
Novartis
InSightec
AstraZeneca
InSightec
Bayer
Mannkind Corporation